Demir Vahit1, Mehmet Kadri Akboga2, Yilmaz Samet3, Ede Hüseyin1. 1. Cardiology Department, Bozok University Hospital, 66200, Yozgat, Turkey. 2. Cardiology Clinic, Turkey Yuksek Ihtisas Education & Research Hospital, 06100, Sihhiye, Ankara, Turkey. 3. Cardiology clinic, Pamukkale University Hospital, 20070, Denizli, Turkey.
Abstract
AIM: We aimed to investigate the relationships between metabolic syndrome (MS) and monocyte to high density lipoprotein cholesterol ratio (MHR) and lymphocyte-to-monocyte ratio (LMR). METHODS: 762 patients (n = 371 MS present and n = 391 MS absent) were enrolled. RESULTS: MHR was significantly higher [13.9 (10.5-18.1) vs 11.1 (8.0-14.8); p < 0.001], whereas LMR was significantly lower [4.5 (3.6-5.7) vs 3.6 (2.9-4.8); p < 0.001] in patients with MS. LMR [OR: 0.796 (95% CI): 0.711-0.892); p < 0.001], MHR [OR: 1.052 (95% CI: 1.018-1.088); p = 0.003] and C-reactive protein [OR: 1.048 (95% CI: 1.032-1.065); p < 0.001] remained as independent variables for the presence of MS. CONCLUSION: The present study shows that both LMR and MHR may be novel and useful indicators of MS.
AIM: We aimed to investigate the relationships between metabolic syndrome (MS) and monocyte to high density lipoprotein cholesterol ratio (MHR) and lymphocyte-to-monocyte ratio (LMR). METHODS: 762 patients (n = 371 MS present and n = 391 MS absent) were enrolled. RESULTS: MHR was significantly higher [13.9 (10.5-18.1) vs 11.1 (8.0-14.8); p < 0.001], whereas LMR was significantly lower [4.5 (3.6-5.7) vs 3.6 (2.9-4.8); p < 0.001] in patients with MS. LMR [OR: 0.796 (95% CI): 0.711-0.892); p < 0.001], MHR [OR: 1.052 (95% CI: 1.018-1.088); p = 0.003] and C-reactive protein [OR: 1.048 (95% CI: 1.032-1.065); p < 0.001] remained as independent variables for the presence of MS. CONCLUSION: The present study shows that both LMR and MHR may be novel and useful indicators of MS.
Entities:
Keywords:
lymphocyte-to-monocyte ratio; metabolic syndrome; monocyte to HDL cholesterol ratio